Delivery Order SPE2DB22D7065-SPE2DB24FH1BK

Award Date 2/22/24
Potential Completion Date 2/23/24
Potential Value $1.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,354.06 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide "REFRESH PLUS 0.5% EYE DROPS UD 50S" products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,974.92 contract is for the provision of "REFRESH PLUS 0.5% EYE DROPS 30S" pharmaceutical products. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that enables Amerisourcebergen Drug Corp to deliver a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,757.43 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S" and has a completion date of February 8, 2024. Amerisourcebergen Drug Corp, operating out of its Corporate Office in Conshohocken, Pennsylvania, is the prime contractor on this order, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of REFRESH PLUS 0.5% EYE DROPS UD 70S. The contract, valued at $2,510.87, has a completion date of March 1, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of pharmaceutical products and medical supplies to the Department of Defense through various contract vehicles. This...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4563894359 REFRESH PLUS 0.5% EYE DROPS 30S. The contract has a completion date of March 8, 2024 and a potential value of $1,053.44. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
This $1,093.42 firm fixed-price delivery order was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of 4,561,837,935 units of REFRESH PLUS 0.5% EYE DROPS UD 50S, a prescription ophthalmic product, with a period of performance ending on August 18, 2023. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $5,547.93 contract is for the provision of "REFRESH PLUS 0.5% EYE DROPS 30S", a pharmaceutical product, to support the Department of Defense's military treatment programs and facilities. No set-aside designation was used for this...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply REFRESH PLUS 0.5% EYE DROPS UD 70S. The contract has a ceiling value of $1,196.48 and a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not part of a set-aside program. Additionally, Amerisourcebergen Drug Corp holds an...
This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The $2,211.18 contract is for the provision of 4563589797 REFRESH PLUS 0.5% EYE DROPS UD 70S, a pharmaceutical product, to support DLA Troop Support Medical facilities and military treatment programs. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $1,450.56 firm fixed price delivery order is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S", a pharmaceutical product, with a performance period through April 1, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) awarded solely to...
  • SPE2DB22D7065
    Indefinite Delivery Contract
  • SPE2DB22D7065-SPE2DB24FH1BK
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,295.31 contract is for the provision of "REFRESH PLUS 0.5% EYE DROPS UD 70S" to support military treatment programs and facilities. This delivery order is issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp by DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.

Generated 5/23/24, 9:47 AM